gemcitabine has been researched along with guanosine triphosphate in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cuddy, DP; Ross, DD | 1 |
| Chapman, AJ; Chen, F; Chubb, S; Gandhi, V; Hertel, LW; Huang, P; Mineishi, S; Nowak, B; Plunkett, W; Yang, Y | 1 |
| Chang, EY; Hahn, TM; Hertel, LW; Lawrence, TS; Shewach, DS | 1 |
| Bergman, AM; Jensen, PB; Munch-Petersen, B; Peters, GJ; Pinedo, HM; Sehested, M; Smid, K; Veerman, G; Voorn, DA | 1 |
4 other study(ies) available for gemcitabine and guanosine triphosphate
| Article | Year |
|---|---|
Consequences of 2',2'-difluorodeoxycytidine (gemcitabine) on replicative DNA synthesis in intact HL-60 cells.
Topics: Antimetabolites, Antineoplastic; Cytarabine; Cytidine Triphosphate; Deoxycytidine; DNA Replication; DNA, Neoplasm; Dose-Response Relationship, Drug; Gemcitabine; Guanosine Triphosphate; Half-Life; HL-60 Cells; Humans; Nucleosides; Peptide Chain Elongation, Translational; Thymine | 1995 |
Cytotoxicity, metabolism, and mechanisms of action of 2',2'-difluorodeoxyguanosine in Chinese hamster ovary cells.
Topics: Adenosine Triphosphate; Animals; Base Sequence; Cell Division; CHO Cells; Cricetinae; Deoxycytidine; DNA; Drug Screening Assays, Antitumor; Gemcitabine; Guanosine Triphosphate; Molecular Sequence Data; Phosphorylation; Purine-Nucleoside Phosphorylase; RNA; Substrate Specificity | 1995 |
Radiosensitization of pancreatic cancer cells by 2',2'-difluoro-2'-deoxycytidine.
Topics: Adenosine Triphosphate; Cell Cycle; Cell Survival; Cytidine Triphosphate; Deoxycytidine; Drug Screening Assays, Antitumor; Gemcitabine; Guanosine Triphosphate; Humans; Pancreatic Neoplasms; Radiation-Sensitizing Agents; Thymine Nucleotides; Tumor Cells, Cultured | 1996 |
Collateral sensitivity to gemcitabine (2',2'-difluorodeoxycytidine) and cytosine arabinoside of daunorubicin- and VM-26-resistant variants of human small cell lung cancer cell lines.
Topics: Adenosine Triphosphate; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arabinofuranosylcytosine Triphosphate; Carcinoma, Small Cell; Cell Survival; Cytarabine; Cytidine Deaminase; Daunorubicin; Deoxycytidine; Deoxycytidine Kinase; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Gemcitabine; Guanosine Triphosphate; Humans; Lung Neoplasms; Nucleoside Deaminases; Teniposide; Thymidine Kinase; Tumor Cells, Cultured; Uridine Triphosphate | 2001 |